Saturday 17 October 2026
Export CBT’s income statement to Excel — free account
Cabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024. In the quarter to June 2026, revenue grew 6.39%, EPS fell 93.6%, free cash flow fell 77.0% and total debt rose 4.77%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.
74.29
1.19
−1.58%
Follow CBT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 11.24% | 17.45% | 19.17% | 20.09% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 5 | 6 | 6 | |
| 4.92% | 7.45% | 8.41% | 8.77% | ||
ROIC |
11.18% | 12.85% | 14.17% | 15.06% | |
Return on Tangible Assets |
8.46% | 12.83% | 13.46% | 14.44% | |
Average Days of Receivables |
73.42 | 67.08 | 62.33 | 65.96 | |
Free Cash Flow per Share |
5.97 | 8.31 | 7.61 | 7.28 | |
Free Cash Flow |
308.00 | 432.00 | 401.00 | 391.00 | |
Capital Expenditures |
(189.00) | (239.00) | (266.00) | (274.00) | |
| Other line items | |||||
Cash ROIC |
9.46% | 13.34% | 13.00% | 12.64% | |
Accounts Receivable Turnover |
5.12 | 5.12 | 5.58 | 5.29 | |
Accounts Payable Turnover |
4.44 | 4.58 | 4.58 | 4.19 | |
Inventory Turnover |
5.12 | 5.06 | 5.18 | 5.25 | |
Average Days of Payables |
87.06 | 81.14 | 77.99 | 85.29 | |
Days of Inventory on Hand |
73.55 | 70.83 | 68.23 | 66.34 | |
Tax Rate |
(0.46) | (0.37) | (0.36) | (0.35) | |
Research and Development Expense of Revenue |
1.51% | 1.59% | 1.61% | 1.59% | |
Selling, General and Administrative Expense of Revenue |
7.62% | 7.44% | 7.29% | 7.00% | |
Share Based Compensation of Revenue |
0.50% | 0.48% | 0.53% | 0.65% | |
Interest Coverage |
6.66 | 7.49 | 7.83 | 8.17 | |
Operating CF/Net income |
2.59 | 2.35 | 2.14 | 2.01 | |
Depreciation/Fixed assets |
0.10 | 0.10 | 0.09 | 0.09 | |
Capex/Depreciation |
(1.05) | (1.41) | (1.68) | (1.78) | |
Revenue per Share |
70.43 | 68.75 | 68.44 | 69.14 | |
Operating CF per Share |
9.63 | 12.90 | 12.66 | 12.38 | |
Capex per Share |
(3.66) | (4.60) | (5.05) | (5.10) | |
Capex to Sales |
0.05 | 0.07 | 0.07 | 0.07 |
Columns are period end dates